Atlas Trials

Ertapenem Versus Meropenem/Imipenem for ESBL+ Gram-negative Infections

Clinical trial NCT01297842 · UNKNOWN

Trial details

NCT number
NCT01297842
Sponsor
Mahidol University
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Drug Safety
Start date
2011-05-01
Primary completion
2013-04-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.